Emergent BioSolutions Inc.EBSNYSE
Loading
Operating Margin Over TimeExpanding
Percentile Rank57
5Y CAGR-11.8%
Studio
Year-over-Year Change

Operating income as a percentage of revenue

5Y CAGR
-11.8%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM14.83%+242.4%
2024-10.42%+85.0%
2023-69.23%-355.1%
2022-15.21%-179.0%
202119.25%-30.8%
202027.80%+169.5%
201910.32%-10.1%
201811.48%-48.2%
201722.16%+2.7%
201621.58%-